High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: Report of 27 affected pregnancies

Prenatal Diagnosis

Volumn 31, Issue 11, 2011, Pages 1046-1053

  Tamura, Deborah ^a   Merideth, Melissa ^b,c   Digiovanna, John J ^a   Zhou, Xiaolong ^a,d   Tucker, Margaret A ^a   Goldstein, Alisa M ^a   Brooks, Brian P ^e   Khan, Sikandar G ^a   Oh, Kyu Seon ^a   Ueda, Takahiro ^a   Boyle, Jennifer ^a   Moslehi, Roxana ^a,f   Kraemer, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Office of the Director   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

^f STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

HCG; HELLP syndrome; Maternal serum screening; Preeclampsia; Pregnancy; Trichothiodystrophy

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CRYPTORCHISM; DISEASE PREDISPOSITION; DNA REPAIR; FEMALE; FETUS; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; LOW BIRTH WEIGHT; MALE; NEWBORN DISEASE; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; TRICHOTHIODYSTROPHY;

ADULT; DNA REPAIR; FEMALE; FETAL DEVELOPMENT; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; TRANSCRIPTION, GENETIC; TRICHOTHIODYSTROPHY SYNDROMES; YOUNG ADULT;

EID: 80055077880     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2829     Document Type: Article

References (35)

1. Aagaard-Tillery KM, Buchbinder A, Boente MP, Ramin KD. 2007. Beckwith-Wiedemann syndrome presenting with an elevated triple screen in the second trimester of pregnancy. Fetal Diagn Ther 22: 18-22.
2. Alkazaleh F, Chaddha V, Viero S, et al. 2006. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. Am J Obstet Gynecol 194: 821-827.
3. Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R. 2005. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther 20: 48-53.
4. Boyle J, Ueda T, Oh KS, et al. 2008. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy. Hum Mutat 29: 1194-1208.
5. Bradford PT, Goldstein AM, Tamura D, et al. 2011. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 48: 168-176.
6. Compe E, Malerba M, Soler L, Marescaux J, Borrelli E, Egly JM. 2007. Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH. Nat Neurosci 10: 1414-1422.
7. Donn SM, Thoene JG. 1985. Prospective prevention of neonatal hyperammonaemia in argininosuccinic acidura by arginine therapy. J Inherit Metab Dis 8: 18-20.
8. Driscoll DA. 2004. Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy. Genet Med 6: 540-541.
9. Emmert S, Ueda T, Zumsteg U, et al. 2009. Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2). Exp Dermatol 18: 64-68.
10. Faghri S, Tamura D, Kraemer KH, DiGiovanna JJ. 2008. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 45: 609-621.
11. Huang T, Alberman E, Wald N, Summers AM. 2005. Triploidy identified through second-trimester serum screening. Prenat Diagn 25: 229-233.
12. Ibdah JA, Bennett MJ, Rinaldo P, et al. 1999. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340: 1723-1731.
13. Itin PH, Sarasin A, Pittelkow MR. 2001. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 44: 891-920.
14. Kang JH, Farina A, Park JH, et al. 2008. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 28: 704-709.
15. Kleijer WJ, Laugel V, Berneburg M, et al. 2008. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst) 7: 744-750.
16. Kleijer WJ, van der Sterre ML, Garritsen VH, Raams A, Jaspers NG. 2007. Prenatal diagnosis of xeroderma pigmentosum and trichothiodystrophy in 76 pregnancies at risk. Prenat Diagn 27: 1133-1137.
17. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. 2007. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145: 1388-1396.
18. Krause TG, Christens P, Wohlfahrt J, et al. 2001. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1). Obstet Gynecol 97: 277-282.
19. Lehmann AR. 2003. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85: 1101-1111.
20. Lepage N, Chitayat D, Kingdom J, Huang T. 2003. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 188: 1354-1359.
21. Liang C, Kraemer KH, Morris A, et al. 2005. Characterization of tiger-tail banding and hair shaft abnormalities in trichothiodystrophy. J Am Acad Dermatol 52: 224-232.
22. Liang C, Morris A, Schlucker S, et al. 2006. Structural and molecular hair abnormalities in trichothiodystrophy. J Invest Dermatol 126: 2210-2216.
23. Milunsky A, Nebiolo L. 1996. Maternal serum triple analyte screening and adverse pregnancy outcome. Fetal Diagn Ther 11: 249-253.
24. Moslehi R, Signore C, Tamura D, et al. 2010. Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet 77: 365-373.
25. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. 2010. New intrauterine growth curves based on United States data. Pediatrics 125: e214-e224.
26. Petrin JH, Meckler KA, Sybert VP. 1998. A new variant of trichothiodystrophy with recurrent infections, failure to thrive and death. Pediatr Dermatol 15: 31-34.
27. Preece MA, Green A. 2002. Pregnancy and inherited metabolic disorders: maternal and fetal complications. Ann Clin Biochem 39: 444-455.
28. Quintero RA, Morales WJ, Gilbert-Barness E, et al. 2000. In utero diagnosis of trichothiodystrophy by endoscopically-guided fetal eyebrow biopsy. Fetal Diagn Ther 15: 152-155.
29. Sarasin A, Blanchet-Bardon C, Renault G, Lehmann A, Arlett C, Dumez Y. 1992. Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br J Dermatol 127: 485-491.
30. Shekhawat PS, Matern D, Strauss AW. 2005. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Pediatr Res 57: 78R-86R.
31. Stefanini M, Botta E, Lanzafame M, Orioli D. 2010. Trichothiodystrophy: from basic mechanisms to clinical implications. DNA Repair (Amst) 9: 2-10.
32. Witters I, Legius E, Devriendt K, et al. 2001. Pregnancy outcome and long term prognosis in 868 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype. J Med Genet 38: 336-338.
33. Witters I, Moerman P, Van AA, Fryns JP. 2002. Physical and psychomotor development of 1799 children born after second trimester amniocentesis for maternal serum positive triple test screening and normal prenatal karyotype. J Med Genet 39: e75.
34. Yaron Y, Cherry M, Kramer RL, et al. 1999. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 181: 968-974.
35. Zhou X, Khan SG, Tamura D, et al. 2010. Brittle hair, developmental delay, neurologic abnormalities, and photosensitivity in a 4-year-old girl. J Am Acad Dermatol 63: 323-328.